-
Deen Islam, Warren Kaplan, Veronika J. Wirtz, Kevin P. Gallagher. The Social Costs of Graduating from Least Developed Country Status: Analyzing the impact of increased protection on insulin prices in Bangladesh. 2020. View Publication
-
Ashigbie PG, Rockers PC, Laing RO, Cabral HJ, Onyango MA, Buleti JPL, Wirtz VJ. Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: a cross-sectional survey in eight counties. BMJ Open. 2020 05 15; 10(5):e035132.View Related Profiles. PMID: 32414824
-
Orubu ESF, Ching C, Zaman MH, Wirtz VJ. Tackling the blind spot of poor-quality medicines in Universal Health Coverage. J Pharm Policy Pract. 2020; 13:40. PMID: 32670594
-
Newton PN, Bond KC. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. Lancet Glob Health. 2020 06; 8(6):e754-e755.View Related Profiles. PMID: 32278364
-
Umeh CA, Rockers PC, Laing R, Wagh O, Wirtz VJ. Public reporting on pharmaceutical industry-led access programs: alignment with the WHO medicine programs evaluation checklist. J Pharm Policy Pract. 2020; 13:5.View Related Profiles. PMID: 32226630
-
Danielle Trachtenberg, Warren Kaplan, Veronika J. Wirtz, Kevin Gallagher. . The effects of trade agreements on imports of biologics: evidence from Chile. Journal of Globalization and Development. 2020. View Publication
-
Umeh CA, Rockers PC, Laing RO, Wagh O, Wirtz VJ. Pharmaceutical industry-led partnerships focused on addressing the global burden of non-communicable diseases: a review of Access Accelerated. Public Health. 2020 Apr; 181:73-79.View Related Profiles. PMID: 31958672
-
Islam MD, Kaplan WA, Trachtenberg D, Thrasher R, Gallagher KP, Wirtz VJ. Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review. Global Health. 2019 12 30; 15(1):88.View Related Profiles. PMID: 31888688
-
Newton PN, Bond KC. Global access to quality-assured medical products: the Oxford Statement and call to action. Lancet Glob Health. 2019 12; 7(12):e1609-e1611.View Related Profiles. PMID: 31708137
-
Rachel Thrasher, Veronika J. Wirtz, Warren A. Kaplan, Kevin P. Gallagher, Hattie Werk. . Rethinking trade treaties and access to medicines: towards a policy oriented research agenda for sustainable development goals. Global Development Policy Center. Boston. 2019. View Publication
-
Ching C, Orubu ESF, Wirtz VJ, Zaman MH. Bacterial antibiotic resistance development and mutagenesis following exposure to subminimal inhibitory concentrations of fluoroquinolones in vitro: a systematic literature review protocol. BMJ Open. 2019 10 30; 9(10):e030747.View Related Profiles. PMID: 31666265
-
Sabine Vogler, Nina Zimmermann, Manuel Alexander Haasis, Zaheer-Ud-Din Babar, Reinhard Busse, Jaime Espin Balbino, Aukje Mantel-Teeuwisse, Fatima Suleman, Veronika J. Wirtz. Can pharmaceutical pricing and reimbursement policies make a difference in promoting equitable access to affordable medicines? From diagnosis to sustainable impact. Journal of Pharmaceutical Policy and Practice. 2019; 12:34. View Publication
-
Orubu ESF, Zaman MH, Rahman MT, Wirtz VJ. Veterinary antimicrobial resistance containment in Bangladesh: Evaluating the national action plan and scoping the evidence on implementation. J Glob Antimicrob Resist. 2020 06; 21:105-115.View Related Profiles. PMID: 31600599
-
Rockers PC, Laing RO, Scott N, Ashigbie P, Lucca EH, Umeh CA, Wirtz VJ. Evaluation of pharmaceutical industry-led access programmes: a standardised framework. BMJ Glob Health. 2019; 4(4):e001659.View Related Profiles. PMID: 31423348
-
Ferrario A, Orubu ESF, Adeyeye MC, Zaman MH, Wirtz VJ. The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists. BMJ Glob Health. 2019; 4(4):e001681.View Related Profiles. PMID: 31406593
-
Laing R, Rockers PC, Umeh C, Wirtz VJ. The Access Observatory Report 2019: Results and Reflections Year Two. 2019. View Publication
-
Kaplan WA, Cárdenas J, Mansilla C, Tobar T, Wirtz VJ. The implementation of the bioequivalence certification policy in Chile: An analysis of market authorization data. PLoS One. 2019; 14(5):e0217334.View Related Profiles. PMID: 31141565
-
Beran D, Laing RO, Kaplan W, Knox R, Sharma A, Wirtz VJ, Frye J, Ewen M. A perspective on global access to insulin: a descriptive study of the market, trade flows and prices. Diabet Med. 2019 06; 36(6):726-733.View Related Profiles. PMID: 30888075
-
Mansilla C, Cárdenas J, Kaplan WA, Wirtz VJ, Kuhn-Barrientos L, Ortíz de Zárate M, Tobar T, Herrera CA. Evaluation of the effects of a generic substitution policy implemented in Chile. BMJ Glob Health. 2017; 2(Suppl 3):e000922.View Related Profiles. PMID: 30899555
-
Moucheraud C, Lenz C, Latkovic M, Wirtz VJ. The costs of diabetes treatment in low- and middle-income countries: a systematic review. BMJ Glob Health. 2019; 4(1):e001258. PMID: 30899566
-
Rockers PC, Laing RO, Ashigbie PG, Onyango MA, Mukiira CK, Wirtz VJ. Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial. Lancet Glob Health. 2019 04; 7(4):e492-e502.View Related Profiles. PMID: 30799142
-
Simão M, Wirtz VJ, Al-Ansary LA, Hill S, Grove J, Gray AL, Nannei C, Hedman L, Das P, Hogerzeil H. A global accountability mechanism for access to essential medicines. Lancet. 2018 12 08; 392(10163):2418-2420. PMID: 30527401
-
Syed N, Rockers PC, Vian T, Onyango M, Laing RO, Wirtz VJ. Access to Antihypertensive Medicines at the Household Level: A Study From 8 Counties of Kenya. Glob Heart. 2018 12; 13(4):247-253.e5.View Related Profiles. PMID: 30245176
-
Onyango MA, Vian T, Hirsch I, Salvi DD, Laing R, Rockers PC, Ashigbie PG, Wirtz VJ. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study. PLoS One. 2018; 13(8):e0201917.View Related Profiles. PMID: 30142218
-
Rockers PC, Reich MR, Kettler H, Wirtz VJ. Commitment to Impact: Strengthening Measurement of Industry-Led Access-to-Medicines Programs. Health Syst Reform. 2018; 4(3):188-193.View Related Profiles. PMID: 30060703
-
Mehrtash H, Laing R, Wirtz VJ. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region. East Mediterr Health J. 2018 Jul 17; 24(5):427-434.View Related Profiles. PMID: 30043961
-
Rockers PC, Laing RO, Wirtz VJ. Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya. BMJ Glob Health. 2018; 3(3):e000828.View Related Profiles. PMID: 29989082
-
Wirtz VJ, Turpin K, Laing RO, Mukiira CK, Rockers PC. Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya. Trop Med Int Health. 2018 08; 23(8):879-885.View Related Profiles. PMID: 29808960; DOI: 10.1111/tmi.13081;
-
Serván-Mori E, Wirtz VJ. Monetary and nonmonetary household consumption of health services and the role of insurance benefits: An analysis of the Mexico's National Household Income and Expenditure Survey. Int J Health Plann Manage. 2018 Oct; 33(4):847-859. PMID: 29790595
-
Hailu S, Rockers PC, Vian T, Onyango M, Laing R, Wirtz VJ. Access to diabetes medicines at the household level in eight counties of Kenya. Journal of Diabetology. 2018; 9(2):45-55. View Publication
-
Barakat D, Rockers PC, Vian T, Onyango MA, Laing RO, Wirtz VJ. Access to asthma medicines at the household level in eight counties of Kenya. Int J Tuberc Lung Dis. 2018 05 01; 22(5):585-590.View Related Profiles. PMID: 29663966
-
Soria-Saucedo R, Lopez-Ridaura R, Lajous M, Wirtz VJ. The prevalence and correlates of severe depression in a cohort of Mexican teachers. J Affect Disord. 2018 07; 234:109-116. PMID: 29525351
-
Wirtz VJ, Moucheraud C. Beyond availability and affordability: how access to medicines affects non-communicable disease outcomes. Lancet Public Health. 2017 09; 2(9):e390-e391. PMID: 29253405
-
Vogler S, Paris V, Ferrario A, Wirtz VJ, de Joncheere K, Schneider P, Pedersen HB, Dedet G, Babar ZU. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. Appl Health Econ Health Policy. 2017 Jun; 15(3):307-321. PMID: 28063134; DOI: 10.1007/s40258-016-0300-z;
-
Kaplan WA, Ashigbie PG, Brooks MI, Wirtz VJ. Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies. J Pharm Policy Pract. 2017; 10:17.View Related Profiles. PMID: 28523128
-
Wirtz VJ, Hogerzeil HV, Gray AL. Essential medicines for universal health coverage - Authors' reply. Lancet. 2017 05 13; 389(10082):1881-1882. PMID: 28513447
-
Rockers PC, Wirtz VJ, Umeh CA, Swamy PM, Laing RO. Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence. Health Aff (Millwood). 2017 Apr 01; 36(4):706-713.View Related Profiles. PMID: 28373337; DOI: 10.1377/hlthaff.2016.1213;
-
Brooks MI, Thabrany H, Fox MP, Wirtz VJ, Feeley FG, Sabin LL. Health facility and skilled birth deliveries among poor women with Jamkesmas health insurance in Indonesia: a mixed-methods study. BMC Health Serv Res. 2017 Feb 02; 17(1):105.View Related Profiles. PMID: 28148258; DOI: 10.1186/s12913-017-2028-3;
-
Rockers PC, Wirtz VJ, Vian T, Onyango MA, Ashigbie PG, Laing R. Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya. BMJ Open. 2016 Nov 25; 6(11):e013386.View Related Profiles. PMID: 27888177; DOI: 10.1136/bmjopen-2016-013386;
-
Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, Gyansa-Lutterodt M, Jing S, Luiza VL, Mbindyo RM, Möller H, Moucheraud C, Pécoul B, Rägo L, Rashidian A, Ross-Degnan D, Stephens PN, Teerawattananon Y, 't Hoen EF, Wagner AK, Yadav P, Reich MR. Essential medicines for universal health coverage. Lancet. 2017 01 28; 389(10067):403-476. PMID: 27832874; DOI: 10.1016/S0140-6736(16)31599-9;
-
Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ. Estimating the Burden of Chagas Disease in the United States. PLoS Negl Trop Dis. 2016 Nov; 10(11):e0005033. PMID: 27820837; DOI: 10.1371/journal.pntd.0005033;
-
Gray AL, Santa-Ana-Tellez Y, J Wirtz V. Impact of the introduction of mandatory generic substitution in South Africa: private sector sales of generic and originator medicines for chronic diseases. Trop Med Int Health. 2016 12; 21(12):1504-1512. PMID: 27671539; DOI: 10.1111/tmi.12785;
-
Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries". Circulation. 2016 10 04; 134(14):e305-e306.View Related Profiles. PMID: 27698055
-
Roche SD, Ketheeswaran P, Wirtz VJ. International short-term medical missions: a systematic review of recommended practices. Int J Public Health. 2017 Jan; 62(1):31-42. PMID: 27592359; DOI: 10.1007/s00038-016-0889-6;
-
Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Leufkens HG, Wirtz VJ. Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis. Health Policy Plan. 2016 Nov; 31(9):1291-6. PMID: 27229872; DOI: 10.1093/heapol/czw066;
-
-
Sun J, Ren L, Wirtz V. How much could be saved in Chinese hospitals in procurement of anti-hypertensives and anti-diabetics? J Med Econ. 2016 Sep; 19(9):881-8. PMID: 27100310; DOI: 10.1080/13696998.2016.1181641;
-
Vogler S, Zimmermann N, Ferrario A, Wirtz VJ, de Joncheere K, Pedersen HB, Dedet G, Paris V, Mantel-Teeuwisse AK, Babar ZU. Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference. J Pharm Policy Pract. 2016; 9:9. PMID: 26981252; DOI: 10.1186/s40545-016-0056-8;
-
Ashigbie PG, Azameti D, Wirtz VJ. Challenges of medicines management in the public and private sector under Ghana's National Health Insurance Scheme - A qualitative study. J Pharm Policy Pract. 2016; 9:6. PMID: 26913200; DOI: 10.1186/s40545-016-0055-9;
-
Gray AL, Wirtz VJ, 't Hoen EF, Reich MR, Hogerzeil HV. Essential medicines are still essential. Lancet. 2015 Oct 24; 386(10004):1601-3. PMID: 26595616; DOI: 10.1016/S0140-6736(15)00514-0;
-
Vogler S, Zimmermann N, Ferrario A, Wirtz VJ, Babar ZU. Challenges and opportunities for pharmaceutical pricing and reimbursement policies. J Pharm Policy Pract. 2015; 8(Suppl 1 Abstracts from the 3rd International PPRI Conference):E1. PMID: 26468394; DOI: 10.1186/2052-3211-8-S1-E1;
-
Vogler S, Zimmermann N, Wirtz VJ, Babar ZU. Policies beyond the crisis: lesson learned. J Pharm Policy Pract. 2015; 8(Suppl 1 Abstracts from the 3rd International PPRI Conference):E2. PMID: 26468395; DOI: 10.1186/2052-3211-8-S1-E2;
-
Vogler S, Zimmermann N, Wirtz VJ, Babar ZU. Policy cooperation and interface issues. J Pharm Policy Pract. 2015; 8(Suppl 1 Abstracts from the 3rd International PPRI Conference):E3. PMID: 26468396; DOI: 10.1186/2052-3211-8-S1-E3;
-
Servan-Mori E, Wirtz V, Avila-Burgos L, Heredia-Pi I. Antenatal Care Among Poor Women in Mexico in the Context of Universal Health Coverage. Matern Child Health J. 2015 Oct; 19(10):2314-22. PMID: 26093688; DOI: 10.1007/s10995-015-1751-9;
-
Servan-Mori E, Heredia-Pi I, Montañez-Hernandez J, Avila-Burgos L, Wirtz VJ. Access to Medicines by Seguro Popular Beneficiaries: Pending Tasks towards Universal Health Coverage. PLoS One. 2015; 10(9):e0136823. PMID: 26407158; PMCID: PMC4583285; DOI: 10.1371/journal.pone.0136823;
-
Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Leufkens HG, Wirtz VJ. Reply to "decrease in penicillin sales in Brazil after over-the-counter restrictions". Antimicrob Agents Chemother. 2015 Sep; 59(9):5864. PMID: 26276894; PMCID: PMC4538527; DOI: 10.1128/AAC.01128-15;
-
Moucheraud C, Wirtz VJ, Reich MR. Evaluating the quality and use of economic data in decisions about essential medicines. Bull World Health Organ. 2015 Oct 01; 93(10):693-699. PMID: 26600611; DOI: 10.2471/BLT.14.149914;
-
Díaz-Portillo SP, Idrovo ÁJ, Dreser A, Bonilla FR, Matías-Juan B, Wirtz VJ. [Clinics adjacent to private pharmacies in Mexico: infrastructure and characteristics of the physicians and their remuneration]. Salud Publica Mex. 2015 Jul-Aug; 57(4):320-8. PMID: 26395797
-
Manne-Goehler J, Reich MR, Wirtz VJ. Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hyg. 2015 Jul; 93(1):108-13. PMID: 25986581; PMCID: PMC4497880; DOI: 10.4269/ajtmh.14-0826;
-
Nigenda G, Wirtz VJ, González-Robledo LM, Reich MR. Evaluating the Implementation of Mexico's Health Reform: The Case of Seguro Popular. Health Syst Reform. 2015 Apr 03; 1(3):217-228. PMID: 31519075
-
Nigenda G, Wirtz VJ, González-Robledo LM, Reich MR. . Evaluating the Implementation of Mexico's Health Reform: The Case of Seguro Popular. Health System and Reform. 2015; 3(1):217–228. View Publication
-
Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Leufkens HG, Wirtz VJ. Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions. Antimicrob Agents Chemother. 2015 Jan; 59(1):105-10. PMID: 25313222; PMCID: PMC4291337; DOI: 10.1128/AAC.03629-14;
-
Manne-Goehler J, Ramsey JM, Salgado MO, Wirtz VJ, Reich MR. Short report: Increasing access to treatment for Chagas disease: the case of Morelos, Mexico. Am J Trop Med Hyg. 2014 Dec; 91(6):1125-7. PMID: 25266353; PMCID: PMC4257633; DOI: 10.4269/ajtmh.14-0357;
-
Heredia-Pi I, Servan-Mori EE, Wirtz VJ, Avila-Burgos L, Lozano R. Obstetric care and method of delivery in Mexico: results from the 2012 National Health and Nutrition Survey. PLoS One. 2014; 9(8):e104166. PMID: 25101781; PMCID: PMC4125173; DOI: 10.1371/journal.pone.0104166;
-
Pérez-Cuevas R, Doubova SV, Wirtz VJ, Servan-Mori E, Dreser A, Hernández-Ávila M. Effects of the expansion of doctors' offices adjacent to private pharmacies in Mexico: secondary data analysis of a national survey. BMJ Open. 2014; 4(5):e004669. PMID: 24852298; DOI: 10.1136/bmjopen-2013-004669;
-
-
Wagner AK, Wirtz VJ, Bigdeli M, Ho WLC, Ross-Degnan D. Medicines in Health Systems (Bigdeli M, Wagner AK, Peters D, eds.). The role of medicines in achieving universal health coverage. World Health Organization. Geneva. 2014.
-
Wirtz VJ, Candia-Fernandez E. Calidad del primer nivel de atención de los Servicios Estatales de Salud: Diagnostico estratégico de la situación actual (Saturno PJ, Gutierrez JP, Armendariz DM, Armenta N, Candia E, Contreras D, Fernandez M, Galvan A, Hernandez JL, Hernandez Avila JE, Palacio LS, Poblano O, Vertiz J, Vieyra W, Wirtz V., eds.). Subcomponente 5.2 Diagnóstico del sistema de suministro de medicamentos en los servicios de salud de la Secretaría de Salud. INSP. Cuernavaca. 2014.
-
Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Dreser A, Leufkens HG, Wirtz VJ. Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico. PLoS One. 2013; 8(10):e75550. PMID: 24146761; PMCID: PMC3797702; DOI: 10.1371/journal.pone.0075550;
-
Van Bever E, Wirtz VJ, Azermai M, De Loof G, Christiaens T, Nicolas L, Van Bortel L, Vander Stichele R. Operational rules for the implementation of INN prescribing. Int J Med Inform. 2014 Jan; 83(1):47-56. PMID: 24168761; DOI: 10.1016/j.ijmedinf.2013.09.004;
-
-
-
Galárraga O, Wirtz VJ, Santa-Ana-Tellez Y, Korenromp EL. Financing HIV programming: how much should low- and middle-income countries and their donors pay? PLoS One. 2013; 8(7):e67565. PMID: 23861772; PMCID: PMC3702499; DOI: 10.1371/journal.pone.0067565;
-
Wirtz VJ, Dreser A, Heredia-Pi I. [Challenges and opportunities for the development of a national pharmaceutical policy in México]. Salud Publica Mex. 2013 May-Jun; 55(3):329-36. PMID: 23912546
-
Wirtz VJ, Herrera-Patino JJ, Santa-Ana-Tellez Y, Dreser A, Elseviers M, Vander Stichele RH. Analysing policy interventions to prohibit over-the-counter antibiotic sales in four Latin American countries. Trop Med Int Health. 2013 Jun; 18(6):665-73. PMID: 23551290; DOI: 10.1111/tmi.12096;
-
Hogerzeil HV, Liberman J, Wirtz VJ, Kishore SP, Selvaraj S, Kiddell-Monroe R, Mwangi-Powell FN, von Schoen-Angerer T. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet. 2013 Feb 23; 381(9867):680-9. PMID: 23410612; DOI: 10.1016/S0140-6736(12)62128-X;
-
Wirtz VJ, Mol PG, Verdijk J, Vander Stichele RH, Taxis K. Use of antibacterial fixed-dose combinations in the private sector in eight Latin American Countries between 1999 and 2009. Trop Med Int Health. 2013 Apr; 18(4):416-25. PMID: 23379471; DOI: 10.1111/tmi.12068;
-
Veronika J. Wirtz, Edson Servan-Mori, Anahi Dreser, Ileana Heredia-Pi, Leticia Ávila-Burgos. Access to and expenditure on medicines in Mexico: challenges and opportunities. Salud Publica Mexico. 2013; 55(sup 2):112-122.
-
Hortensia Reyes Morales, Sergio Flores-Hernández, Alma L. Sauceda-Valenzuela, Jesus J. Vértiz-Ramírez, Clara Juárez-Ramírez, Veronika J. Wirtz, Ricardo Pérez-Cuevas, Mauricio Avila-Hernandez. Perception of quality of ambulatory health care services in Mexico. Salud Publica Mexico. 2013; 55(sup2):100-105.
-
Leticia Avila-Burgos, Edon Serván-Mori E, Veronika J. Wirtz, Sandra G. Sosa-Rubí, Aaron Salinas-Rodríguez. Estimación del Efecto del Seguro Popular sobre el gasto en salud en hogares mexicanos a diez años de su implementación, ENSANUT 2012. Salud Publica Mexico. 2013; 55(sup 2):91-99.
-
Ávila-Burgos L, Serván-Mori E, Wirtz VJ, Sosa-Rubí SG, Salinas-Rodríguez A. [Effect of Seguro Popular on health expenditure in Mexican households ten years after its implementation]. Salud Publica Mex. 2013; 55 Suppl 2:S91-9. PMID: 24626719
-
Reyes-Morales H, Flores-Hernández S, Sauceda-Valenzuela AL, Vértiz-Ramírez Jde J, Juárez-Ramírez C, Wirtz VJ, Pérez-Cuevas R. [Users' perception about of quality ambulatory healthcare services in Mexico]. Salud Publica Mex. 2013; 55 Suppl 2:S100-5. PMID: 24626684
-
Wirtz VJ, Serván-Mori E, Heredia-Pi I, Dreser A, Ávila-Burgos L. [Factor associated with medicines utilization and expenditure in Mexico]. Salud Publica Mex. 2013; 55 Suppl 2:S112-22. PMID: 24626686
-
Dreser A, Vázquez-Vélez E, Treviño S, Wirtz VJ. Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation. BMC Public Health. 2012; 12:1051. PMID: 23217185; PMCID: PMC3562509; DOI: 10.1186/1471-2458-12-1051;
-
Ruiz-Rodríguez M, Wirtz VJ, Idrovo AJ, Angulo ML. Access to medicines among internally displaced and non-displaced people in urban areas in Colombia. Cad Saude Publica. 2012 Dec; 28(12):2245-56. PMID: 23288058
-
-
Nguyen HT, Wirtz VJ, Haaijer-Ruskamp FM, Taxis K. Indicators of quality use of medicines in South-East Asian countries: a systematic review. Trop Med Int Health. 2012 Dec; 17(12):1552-66. PMID: 22974440; DOI: 10.1111/j.1365-3156.2012.03081.x;
-
Gómez-Dantés O, Wirtz VJ, Reich MR, Terrazas P, Ortiz M. A new entity for the negotiation of public procurement prices for patented medicines in Mexico. Bull World Health Organ. 2012 Oct 1; 90(10):788-92. PMID: 23109747; PMCID: PMC3471060; DOI: 10.2471/BLT.12.106633;
-
Gutiérrez-Mendoza LM, Schwartz B, Méndez de Lira Jde J, Wirtz VJ. Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico. Bull World Health Organ. 2012 Oct 1; 90(10):782-7. PMID: 23109746; PMCID: PMC3471052; DOI: 10.2471/BLT.11.101733;
-
-
Wirtz VJ, Santa-Ana-Tellez Y, Servan-Mori E, Avila-Burgos L. Heterogeneous effects of health insurance on out-of-pocket expenditure on medicines in Mexico. Value Health. 2012 Jul-Aug; 15(5):593-603. PMID: 22867767; DOI: 10.1016/j.jval.2012.01.006;
-
Adesina A, Wirtz VJ, Dratler S. Reforming antiretroviral price negotiations and public procurement: the Mexican experience. Health Policy Plan. 2013 Jan; 28(1):1-10. PMID: 22375026; DOI: 10.1093/heapol/czs015;
-
Wirtz VJ, Santa-Ana-Tellez Y, Trout CH, Kaplan WA. Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America. Health Policy Plan. 2012 Dec; 27(8):638-48.View Related Profiles. PMID: 22367770; DOI: 10.1093/heapol/czs011;
-
Luis Meave Gutierrez-Mendoza, Brian Schwartz, José de Jesús Mendez-de-Lira, Veronika J. Wirtz. Storage, distribution and dispensing of oseltamivir during the first month after the H1N1 influenza outbreak in 2009: Lessons from Mexico Lessons from the field. Bulletin of the World Health Organization. 2012; 90(10):782-787.
-
Avila Burgos L, Wirtz VJ, Servan Mori E, Bautista Arredondo S, Abigail Barroso C, Gonzalez Block MA. Encuesta Nacional de Salud y Nutrición, Resultados Nacionales 2012. Utilización de servicios de salud. Capítulo 1: Utilización de servicios. Instituto Nacional de Salud Pública. Cuernavaca. 2012.
-
Galárraga O, Wirtz VJ, Figueroa-Lara A, Santa-Ana-Tellez Y, Coulibaly I, Viisainen K, Medina-Lara A, Korenromp EL. Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries. Pharmacoeconomics. 2011 Jul; 29(7):579-99. PMID: 21671687; DOI: 10.2165/11586120-000000000-00000;
-
Sesma-Vázquez S, Gómez-Dantés O, Wirtz VJ, Castro-Tinoco M. [Supply prescription filling and out-of-pocket expenditures on medicines in public hospitals in Mexico in 2009]. Salud Publica Mex. 2011; 53 Suppl 4:470-9. PMID: 22282209
-
Anahi Dreser, Veronika J. Wirtz, Yared Santa Ana Téllez. Consumo de antibacterianos en América Latina: la importancia de analizar sus causas e implicaciones. La Gazeta de Infectología y Microbiología Cliníca Latinoamericano. 2011; 1(2):36-41.
-
Wirtz VJ, Candida-Fernandez E, Soria-Saucedo R. Secretaria de Salud. Observatorio del desempeno ambulatorio. Chapter VII: Propuestas de fortalecimiento del ciclo de suministro de medicamentos en las UAA de los SESA. SSA. Mexico. 2011.
-
Dreser A, Wirtz VJ, Leyva-Flores R. Las farmacias, los farmacéuticos y el uso adecuado de medicamentos en América Latina (Homedes N, Ugalde A, eds.). Capítulo 1. Las farmacias mexicanas: Regulación y políticas. Lugar. Buenos Aires. 2011; 27-57.
-
Wirtz VJ, Leyva-Flores R, Dreser A, Corbett KK. Las farmacias, los farmacéuticos y el uso adecuado de medicamentos en América Latina (Homedes N, Ugalde A, eds.). Capítulo 2. Organización y funcionamiento de las farmacias en México. Lugar. Buenos Aires. 2011; 59-81.
-
Sergio Sesma-Vázquez, Octavio Gómez-Dantés, Veronika J. Wirtz, Manuel Castro-Tinoco. Abasto, surtimiento y gasto de bolsillo en medicamentos en hospitales públicos de México en 2009. Salud Publica de Mexico. 2011; 53(Sup 4):470-479.
-
Bautista-Arredondo S, Wirtz VJ, Bertozzi SM. Improving access to treatment for HIV in sub-Saharan Africa. BMJ. 2010; 341:c6546. PMID: 21123343; DOI: 10.1136/bmj.c6546;
-
Sauceda-Valenzuela AL, Wirtz VJ, Santa-Ana-Téllez Y, de la Luz Kageyama-Escobar M. Ambulatory health service users' experience of waiting time and expenditure and factors associated with the perception of low quality of care in Mexico. BMC Health Serv Res. 2010; 10:178. PMID: 20573225; PMCID: PMC2903586; DOI: 10.1186/1472-6963-10-178;
-
Bautista-Arredondo S, Martz TE, Wirtz VJ, Bertozzi SM. Optimizing HIV treatment programs. Curr Opin HIV AIDS. 2010 May; 5(3):232-6. PMID: 20539079; DOI: 10.1097/COH.0b013e32833860d3;
-
Wirtz VJ, Dreser A, Gonzales R. Trends in antibiotic utilization in eight Latin American countries, 1997-2007. Rev Panam Salud Publica. 2010 Mar; 27(3):219-25. PMID: 20414511
-
Wirtz VJ, Russo G, Kageyama-Escobar Mde L. Access to medicines by ambulatory health service users in Mexico: an analysis of the national health surveys 1994 to 2006. Salud Publica Mex. 2010 Jan-Feb; 52(1):30-8. PMID: 20464251
-
Wirtz VJ. Formación, empleo y regulación de los recursos humanos para la salud. Bases para su planeación estratégica (Nigenda G, Ruiz JA, eds.). Capitulo 5. Químico-fármaco-biólogos. Cendex. Bogota. 2010.
-
Wirtz VJ, Forsythe S, Valencia-Mendoza A, Bautista-Arredondo S. Factors influencing global antiretroviral procurement prices. BMC Public Health. 2009; 9 Suppl 1:S6. PMID: 19922690; PMCID: PMC2779508; DOI: 10.1186/1471-2458-9-S1-S6;
-
Gutiérrez-Luna A, Angeles-Llerenas A, Wirtz VJ, Del Río AA, Zamilpa-Mejía L, Aranda-Flores C, Viramontes JL, Lazcano-Ponce E. Strategies and ethical considerations for the recruitment of young men who have sex with men: challenges of a vaccination trial in Mexico. Clin Trials. 2009 Aug; 6(4):365-72. PMID: 19625328; DOI: 10.1177/1740774509340058;
-
Wirtz VJ, Dreser A, Leyva R. [The debate on self medication]. Salud Publica Mex. 2009 May-Jun; 51(3):179-80. PMID: 19967299
-
Wirtz VJ, Dreser A, Levya R. El debate sobre la automedicación. Revista de Salud Pública. 2009; 51(3):179.
-
Wirtz VJ, Taxis K, Dreser A. Pharmacy customers' knowledge of side effects of purchased medicines in Mexico. Trop Med Int Health. 2009 Jan; 14(1):93-100. PMID: 19017308; DOI: 10.1111/j.1365-3156.2008.02186.x;
-
Ruiz-Rodríguez M, Wirtz VJ, Nigenda G. Organizational elements of health service related to a reduction in maternal mortality: the cases of Chile and Colombia. Health Policy. 2009 May; 90(2-3):149-55. PMID: 18995922; DOI: 10.1016/j.healthpol.2008.09.006;
-
Gonzales R, Corbett KK, Wirtz V, Dreser A. Drug Resistant Infections in Poor Countries: A shrinking window of opportunity. BMJ. 2008 Apr 26; 336(7650):948-9. PMID: 18397943; PMCID: PMC2335223
-
Wirtz VJ, Reich MR, Hernández-Avila M. [Research to support pharmaceutical policies]. Salud Publica Mex. 2008; 50 Suppl 4:S427-8. PMID: 19082252
-
Wirtz VJ, Reich MR, Leyva Flores R, Dreser A. Medicines in Mexico, 1990-2004: systematic review of research on access and use. Salud Publica Mex. 2008; 50 Suppl 4:S470-9. PMID: 19082258
-
Dreser A, Wirtz VJ, Corbett KK, Echániz G. [Antibiotic use in Mexico: review of problems and policies]. Salud Publica Mex. 2008; 50 Suppl 4:S480-7. PMID: 19082259
-
Ralph Gonzalez, Kitty Corbett, Veronika J. Wirtz, Anahi Dreser. Quality improvement interventions for resistant infections in developing countries. A shrinking window of opportunity. British Medical Journal. 2008; 336:948-49.
-
Wirtz VJ, Reich M, Hernandez Avila M. Investigación para sustentar políticas farmacéuticas. Salud Publica de Mexico. 2008; 50:S427-428.
-
Angeles-Llerenas AR, Wirtz V, Lara-Alvarez CF. The role and responsibilities of witnesses in the informed consent process. Dev World Bioeth. 2009 Apr; 9(1):18-25. PMID: 18370932
-
Veronika Wirtz, Alan Cribb, Nick Barber. The use of informed consent for mediation treatment in hospital – qualitative study of the views of doctors and nurses. Clinical Ethics. 2007; 2(1):36-41.
-
Ugalde A, Wirtz V. Estudio de inmigración y fuerza laboral global de farmacéuticos. [Study of immigration and global work force in pharmacy.]. Boletín Fármacos. 2006; 9(3):155-156.
-
Leyva R, Wirtz V, Dreser A, Reich M. Reseña: Hacia una política farmaceútica integral para México. [Towards a coherent pharmaceutical policy in Mexico.]. Salud Publica de Mexico. 2006; 48(3):179-810.
-
Wirtz V, Cribb A, Barber N. Patient-doctor decision-making about treatment within the consultation--a critical analysis of models. Soc Sci Med. 2006 Jan; 62(1):116-24. PMID: 15992980
-
Wirtz V, Cribb A, Barber N. Reimbursement decisions in health policy--extending our understanding of the elements of decision-making. Health Policy. 2005 Sep 8; 73(3):330-8. PMID: 16039351
-
Veronika Wirtz, Alan Cribb, Nick Barber. Reimbursement decision in health policy – extending our understanding of the elements of decision-making. Health Policy. 2005; 73:330-338.
-
Wirtz VJ, Leyva R, Dreser A, Angeles A, Reich MR. Observaciones sobre la propuesta de la nueva política de medicamentos en México. [Observation about a new pharmaceutical policy proposal in Mexico]. Boletín Fármacos. 2005; 8(5):56-58.
-
Taxis K, Wirtz V, Barber N. Variations in aseptic techniques during preparation and administration of intravenous drugs-an observation-based study in the UK and in Germany. J Hosp Infect. 2004 Jan; 56(1):79-81. PMID: 14706281
-
Wirtz V, Cribb A, Barber N. Understanding the role of "the hidden curriculum" in resource allocation--the case of the UK NHS. Health Care Anal. 2003 Dec; 11(4):295-300. PMID: 14769011
-
Wirtz V, Taxis K, Barber ND. An observational study of intravenous medication errors in the United Kingdom and in Germany. Pharm World Sci. 2003 Jun; 25(3):104-11. PMID: 12840963
-
Wirtz V. Bryony Dean. Informed consent – what are the implications for pharmacists?. Pharmacy in Practice. 2001; 11:217-220.